Stay updated on Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.

Latest updates to the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe clinical trial record is displayed with its study design, treatment arms, eligibility criteria, outcome measures, and record dates, including that the study is completed and results are posted.SummaryDifference51%

- Check17 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedA site-wide NIH notice about transitioning terminology from “Artificial Intelligence” to “Super Intelligence” appears, and the footer revision advances from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check38 days agoChange DetectedThe displayed site revision in the footer advances from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now displays a 403 Forbidden error, preventing access to the study record and its associated documents. This change hides the study details that were previously visible on the page.SummaryDifference19%

- Check66 days agoChange DetectedThe page revision label was updated to v3.7.0, signaling an update to the page. The study content and displayed information remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.